Strategic CFO Support for Scaling Life Sciences Companies

With over 25 years of international experience in the life sciences sector, I provide fractional CFO services tailored to early-stage biotech and medtech companies. My work focuses on building scalable finance and administrative functions, driving financial planning and scenario modeling, and supporting capital raises through investor engagement and due diligence. As a former CFO of both private and publicly traded companies across the U.S. and Europe, I bring a pragmatic and collaborative approach to help founders and boards navigate growth, governance, and strategic inflection points such as IPOs and M&A. I’m a responsive partner committed to clarity, integrity, and long-term value creation.